Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer Read more
Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment Read more
SMi’s Highly Potent Active Pharmaceutical Ingredients 2018 Conference are Hosting 2 Workshops! Read more